BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jackson B, Con D, Ma R, Gorelik A, Liew D, De Cruz P. Health care costs associated with Australian tertiary inflammatory bowel disease care.Scand J Gastroenterol. 2017;52:851-856. [PMID: 28509590 DOI: 10.1080/00365521.2017.1323117] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 van Linschoten RCA, Visser E, Niehot CD, van der Woude CJ, Hazelzet JA, van Noord D, West RL. Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Aliment Pharmacol Ther 2021;54:234-48. [PMID: 34114667 DOI: 10.1111/apt.16445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Con D, van Langenberg DR, Vasudevan A. Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study. World J Gastroenterol 2021; 27(38): 6476-6488 [PMID: 34720536 DOI: 10.3748/wjg.v27.i38.6476] [Reference Citation Analysis]